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Abstract 
Objective: 
In positron emission tomography (PET) with F-18-fluorodeoxyglucose (FDG), 
non-tumorous focal uptake is often observed around the lumbar spinous processes 
(LSPs). Close approximation of LSPs with sclerosis is often seen, which is called 
Baastrup disease. The aim of this study was to characterize this finding in terms of 
location and subjects’ age and investigate the relation between PET and CT findings. 
Methods: 
The PET/CT scans of 40 patients each in the fifth, sixth, seventh, eighth, and 
ninth decades were screened for FDG uptake around the LSPs from L1-2 through L5-S1. 
Patients with metastasis to the lumbar spine or recent chemotherapy or rheumatoid 
arthritis-related disease were excluded. Focal uptake greater than blood pool activity 
was considered positive. Positive uptake was compared among the ages and locations. 
We also evaluated the relationship between FDG uptake and CT morphology. 
Results: 
Overall, focal uptake was observed in 122 LSPs in 71 patients. At least one 
positive uptake was seen in 9, 21, 15, 12, and 14 of 40 patients (16, 30, 30, 20, and 26 
of 200 regions) in each age group of 40’s through 80’s, respectively (p=0.12). As for the 
Manuscript text (must not contain any author information)
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location, uptake around L1-2, L2-3, L3-4, L4-5, and L5-S1 was observed in 19, 22, 39, 
35, and 7 regions, respectively (p<0.01). There was no statistically significant difference 
in PET positivity among the five age groups, but positive uptake was predominantly 
seen in L3-4. Degeneration on CT was apparent in 58, 74, 108, 123, and 144 regions in 
each age group, respectively (p<0.01), and in 38, 79, 131, 151, and 108 regions in each 
location, respectively (p<0.01). The PET positive ratio was higher in CT positive group 
than in CT negative group (14% vs. 10%, p<0.05), but there was no significant 
difference of quantitative values (p=0.10). Of 42 regions in 27 patients who had serial 
PET/CT scans that were initially PET-positive, 35 regions (83%) turned negative on a 
later PET-scan. 
Conclusions: 
Focal uptake around the LSPs was commonly seen in the mid-lumbar vertebrae, 
independent of age, and was not always correlated with morphological changes. This 
uptake should not be assumed to represent osseous metastasis. 
 
Key Words: Positron-emission tomography; Computed Tomography; Spine; Lumbar 
spinous process; Baastrup disease  
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Introduction 
Positron emission tomography (PET) using F-18-fluorodeoxyglucose (FDG) is 
a useful modality to detect metabolically active lesions, and has been widely accepted as 
being especially helpful in staging, restaging, and monitoring therapeutic response in 
many malignant diseases [1]. However, it is well known that FDG is not a 
tumor-specific agent, and accumulates in active inflammatory foci as well. Therefore, 
when interpreting PET images, we need to consider whether elevated FDG uptake is 
representing a malignant tumor or a benign process. 
There are some tissues in which FDG accumulates physiologically [2], such as 
brain, myocardium, liver, and bowel. Benign FDG avidity has been reported in 
degenerative arthritis and inflammatory diseases [3-5]. FDG uptake in degenerative 
spinal changes, such as osteophytes, disk disease, and facet joint disease, is quite 
common [3,4]. It is also observed around the lumbar spinous processes (LSPs). 
Baastrup disease, which is also known as a kissing spine, is characterized by 
the close approximation and contact of adjacent spinous processes with sclerosis [6-11]. 
The morphological appearance and features on computed tomography (CT) or magnetic 
resonance (MR) images have been demonstrated [11-16]. The characteristics and 
incidence of this entity on FDG-PET have not been fully investigated, although there 
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are some case reports demonstrating localized FDG uptake between two adjacent 
spinous processes with Baastrup disease [17-19]. 
The purpose of this study was to investigate the characteristics of FDG uptake 
around the LSPs, which may be due to Baastrup disease, in terms of location, CT 
findings, patient age, and time course. 
 
Materials and Methods 
Patients 
To ensure an equal age spread, patients were stratified into five age categories 
(40s, 50s, 60s, 70s, and 80s). For each age category, 20 consecutive male patients and 
20 female patients, who underwent whole body FDG-PET/CT scan from May 2009 to 
October 2009 in our institute, were selected for analysis; a total of 200 patients were 
analyzed. Patients who had bone metastasis in the lumbar spine, rheumatoid 
arthritis-related disease, such as polymyalgia rheumatica or seronegative 
spondyloarthropathy, or who had received chemotherapy or radiotherapy to the lumbar 
vertebrae within 3 months before the examination were excluded. For all eligible 
patients, we confirmed the absence of bone metastasis for a follow-up period ending 
October 2013 by examining medical records, CT, or MRI findings after their PET/CT 
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examinations. For patients who had positive PET findings and underwent another 
PET/CT scan during the follow-up period without chemo/hormonal therapy, we 
evaluated the time-dependent change of PET and CT findings. This retrospective study 
was approved by the institutional review board and ethics committee of our institute, 
and written informed consent was obtained from each patient for their data access. 
 
PET/CT scanning 
Patients fasted for at least 4 h before the examination, and their plasma glucose 
level was measured just before the administration of F-18-FDG (3.7 MBq/kg of body 
weight). There were no patients with a plasma glucose level greater than 200 mg/dL 
(11.1 mmol/L) in this population. Approximately 1 h after injection, PET/CT images 
were acquired with a PET/CT scanner (Discovery ST Elite; GE Healthcare, Waukesha 
Wisconsin, USA) that integrated a bismuth germinate crystal PET system with a 
16-slice multi-detector-row CT scanner. CT scanning was performed immediately 
before PET emission scanning using the following settings: 120 kVp tube voltage, 
20–100mA tube current (automatic setting), 0.6 s per tube rotation, pitch 1.75, and 3.75 
mm section thickness. CT images were reconstructed by filtered back projection into 
512 × 512 pixel images. PET emission scanning was performed with an acquisition time 
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of 2–3 min per bed position. The data were reconstructed into 128 × 128 pixel images 




PET/CT images were evaluated by two physicians, each of whom was a 
board-certified radiologist and nuclear medicine physician, using consensus in cases of 
disagreement. The PET/CT data of all 200 patients were evaluated on a workstation 
(Advantage workstation version 4.4; GE Healthcare, Waukesha WI, USA) with CT 
multiplanar reconstruction images of 3.27 mm thickness. Two CT criteria were 
assessed: 1) close approximation and contact between apposed spinous processes, 2) 
sclerosis of the superior and inferior portions of adjacent processes. The presence of 
both was scored as positive on CT [7-11]. PET images were evaluated in terms of focal 
increased FDG uptake around the LSPs. The uptake in a region was considered positive 
on PET when it was localized and greater than the blood pool activity, defined as the 
activity in the aortic arch. The maximum standardized uptake value (SUVmax) was 
calculated in PET-positive cases. Positivity was compared among the age decades (fifth 
through ninth) and locations (L1-2, L2-3, L3-4, L4-5, and L5-S1). Further, we evaluated 
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the relationship between uptake on PET and morphological changes on CT. If a patient 
had serial PET/CT scans, temporal changes in the findings were evaluated. Statistical 
analysis was performed using the chi-squared test and Mann-Whitney U test. A P value 
< 0.05 was considered statistically significant. 
 
Results 
In 1000 regions in 200 patients, positive FDG uptake around the LSP was 
observed in 122 regions in 71 patients (63 regions in 35 males and 59 regions in 36 
females). The SUVmax was 0.9–3.1, with a mean of 1.53. There was no statistically 
significant difference in overall PET positivity between males and females. 
Degenerative changes on CT images were observed in 507 regions in 170 patients (227 
regions in 81 males and 280 regions in 89 females). No statistically significant gender 
difference was found in CT positivity. A representative case is shown in Figure 1. 
Figure 2 (patients) and Table 1 (regions) show the distribution of positive uptake foci 
by decade. There was no statistically significant difference in PET positivity among 
these five age groups (Chi-square test, P = 0.12). Conversely, the frequency of 
degenerative changes on CT increased with age (Chi-square test, P < 0.01) (Table 1). 
Table 2 displays PET-positive uptake according to location in the lumbar spine. 
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Positive uptake on PET was predominantly seen in the mid-lumbar region, especially in 
L3-4, and rarely seen in L5-S1. There was statistically significant difference in PET 
positivity among location (Chi-square test, P < 0.01). While degenerative changes on 
CT tended to be observed in the mid- to lower-lumbar spine. There was statistically 
significant difference in CT positivity among location (Chi-square test, P < 0.01). 
Increased FDG uptake was identified in 72 of 507 regions (14%) with 
degenerative change and in 50 of 493 regions (10%) without degenerative change on 
CT (Chi-square test, P < 0.05). In addition, regions with morphological changes on CT 
tended to show higher uptake, without statistical significance (Mann-Whitney U test, 
P=0.10) (Table 3). 
Of 71 patients with positive PET findings, 27 underwent another PET/CT scan 
and during the follow-up period. These patients did not undergo chemotherapy, 
hormonal therapy, intensive steroid or immunosuppressant treatment. The second scans 
were performed 3–57 months (mean 16.3 months) after the initial scan. The time 
courses of PET and CT findings are demonstrated in Figure 3. Thirty-five of 42 regions 
(83%) with positive FDG uptake on the first scan turned negative on the second scan, 
whereas all 62 regions with positive CT findings on the first scan remained positive on 
the second scan. In 17 regions with FDG uptake, but no morphological changes on CT, 
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on the first scan, degenerative changes appeared on the second scan in only four regions 
(24%). In 135 regions in these 27 patients, CT findings changed from negative to 
positive in 10 regions, while did not change in the remaining 125 regions. There was no 
significant difference of intervals between the changed group and the unchanged group 
(Mann-Whitney U test, P=0.21). 
 
Discussion 
Uptake around the LSP was often seen in the mid-lumbar spine independent of 
age, while morphological degenerative changes on CT predominated in the lower 
lumbar spine in elderly persons. In some regions, the uptake corresponded to 
degeneration observed in Baastrup disease. However, there were some regions where 
the uptake was seen without any degenerative changes on CT. Therefore, it is 
considered the uptake around the LSP is not always correlated with the morphological 
changes; Baastrup disease. 
Baastrup disease is characterized by the close approximation and contact of 
adjacent spinous processes with associated osteosclerosis on CT, and bursitis on MRI. It 
has been reported that repetitive strain on the interspinous ligaments leads to their 
degeneration and collapse, causing traction enthesopathy and formation of interspinous 
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bursae [5,7-9,12], with osseous proliferation and eburnation of the spinous processes 
[3,7,9]. In our subjects, a statistically significant difference was found in positive uptake 
ratios, dependent on the presence or absence of morphological changes on CT (Table 3). 
This suggests that focal FDG uptake around the LSP may be related to degenerative 
changes. Focal FDG uptake was seen in about 10% of cases when degenerative change 
was not observed on CT. In these cases, uptake might reflect inflammation or rupture of 
interspinous ligament, or bursitis, as reported by MRI studies [11-16]. 
It is reported that Baastrup disease occurs with higher frequency in older 
patients [9-11]. Our findings are consistent with this. In addition, Aliyev et al. reported 
that intensity of FDG uptake (SUVmax) in the spinous processes generally increases 
with age without statistically significant difference [20]. In our population, focal FDG 
uptake around the LSP was predominantly observed in middle-aged patients (50s-60s), 
though not to a statistically significant degree, which is also considered similar with the 
previous reports. 
The peak age for PET positivity was somewhat earlier than that for CT 
positivity, which may be posited to be due to FDG accumulation, reflecting an earlier 
stage of degenerative change of the spinous processes or interspinous ligaments, and/or 
interspinous bursitis not visible on CT. Degenerative change on CT was commonly seen 
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in the lower lumbar spine, but FDG uptake was predominantly seen in the mid-lumbar 
spine, and was an unusual finding at L5-S1. Focal FDG uptake around the LSP and 
degenerative changes on CT were similar in distribution except at L5-S1. Owing to 
lordosis of the lumbar spine, the spinous processes of L5 is originally and commonly 
closed to that of S1. Moreover, the shape of lumbar vertebrae is different from that of 
sacral vertebrae. Each lumbar spinous process (L1-2 - L4-5) is in parallel, with wide 
contact area of apposing spinous processes. On the other hand, the spinous processes in 
L5 and S1 are not in parallel, due to the physiological lumbar lordosis and the 
difference of the each vertebral shape. For this reason, the contact area of L5 and S1 
spinous process may be relatively smaller, resulting in less active inflammatory change 
with FDG uptake. In addition, as compared with data reported by Kwong et al., CT 
positivity was also higher in other locations, which is considered probably because of 
the difference of image quality of CT, i.e. low-dose CT in our study vs. diagnostic CT 
in Kwong's study. 
In 27 patients who had serial scans, 35 (83%) of 42 regions with positive FDG 
uptake at the first scan turned negative at the second scan. As expected, all 62 regions 
with positive CT findings at the first scan remained unchanged at the second scan. 
There were 17 regions in which PET was positive and CT was negative at the first scan, 
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and PET turned negative at the second scan. In these 17 regions, degeneration on CT 
was newly seen at the second scan only in four regions, suggesting that focal 
accumulation around the LPS does not always result in degenerative change later. 
There was no statistically significant difference in overall frequency of LSP 
FDG uptake between males and females. However, comparing each age group, the peak 
of PET positivity in females appeared slightly earlier than that in males (Figure 2). This 
may be related to the higher frequency of age-related LSP degenerative changes in peri- 
and post-menopausal females [7], but the accurate reason remains unknown. Further 
investigations are required to address this issue. 
Some limitations of this study include the quality of CT images, which was 
reduced to redundant radiation exposure. Additionally, evaluation by MRI was not 
performed and we did not compare PET images with MRI images. For this reason, we 
might not have evaluated soft tissue inflammatory change correctly. Although Baastrup 
disease causes low back pain [7-10,12-14,17], we did not evaluate patient symptoms in 
this retrospective study. Even if patients had back pain, it might be difficult to correlate 
the PET/CT finding with their symptoms, because many factors such as disk 
degeneration and facet osteoarthritis as well as Baastrup disease can cause back pain. 
Owing to the retrospective design, the range between the two scans in 27 patients varies. 
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Unsettled period and any therapies might affect the FDG uptake, although we excluded 
patients who underwent chemotherapy or hormonal therapy during their follow-up 
period. 
Conclusions 
FDG uptake around the LSP was often seen in the mid-lumbar spine, regardless 
of the patient’s age. This uptake may represent a complex of degenerative changes in 
apposed spinous processes/inflammation of the interspinous process ligament/bursitis. 
As this commonly observed focal uptake corresponds to bone with or without some 
morphological changes, it should not be misjudged as bone metastasis. 
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Figure Legends 
Figure 1 
A 60-year-old woman with a history of appendectomy for appendiceal follicular 
lymphoma. Coronal images of CT (a), PET/CT fusion (b), PET (c), and sagittal images 
of CT (d), PET/CT fusion (e), PET (f) are demonstrated. Focal uptake is observed 
(SUVmax = 3.1), corresponding to the lower portion (L3-4) of degenerated L3 and L4 
spinous processes (arrows).  
 
Figure 2: Frequency of PET positivity by age group. 
PET positivity was found most frequently in the sixth decade. The peak of PET 
positivity in females appeared a little earlier than that in males. There was no 
statistically significant difference in overall frequency of FDG uptake between males 
and females.  
 
Figure 3: Temporal changes of PET and CT findings between the first and the second 
scans. 
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Thirty-five of 42 regions (83%) with positive uptake turned negative at the second PET 
scan, independent of CT findings, while all 62 regions with positive CT findings on the 
first scan remained positive on the second scan.  
(+), positive; (-), negative 
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Table 1. Number of positive regions in each age group 
 
 
Age group PET CT 
 40s 16 (8%) 58 (29%) 
 50s  30 (15%) 74 (37%) 
 60s  30 (15%) 108 (54%) 
 70s  20 (10%) 123 (62%) 
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Table 2. Number of positive regions in each location 
 
Location PET CT 
 L1-2 19 (10 %) 38 (19%) 
 L2-3 22 (11%) 79 (40%) 
 L3-4 39 (20%) 131 (66%) 
 L4-5 35 (18%) 151 (76%) 
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Table 3. Relationship between CT and PET findings for 1000 regions in 200 patients 
Total number of regions        PET findings       SUVmax 
         Positive      Negative 
CT positive 507        72 (14%)     435 (86%)       1.19±0.32 
CT negative 493        50 (10%)     443 (90%)       1.16±0.25 
 
